Over the past decade, managers have awakened to the power of analytics. Sophisticated computers and software have given companies access to immense troves of data: According to one estimate, ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their body ...

You may have seen the reports. Subaru is asking consumers on the brand’s website whether or not they would be interested in a manual transmission SUV, even going as far as to mention the Outback ...

Performance and fee structures, once potent differentiators, are no longer enough to entice today’s evolving investors. Thoughtfully crafting the client journey is the key to unlocking and ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Sarah Witman Sarah Witman is a writer focused on batteries and charging ...